JP6619211B2 - 細胞核輸送受容体ｋｐｎａ２タンパク質に結合するアプタマー、及びそれを用いたｋｐｎａ２タンパク質の機能阻害 - Google Patents

細胞核輸送受容体ｋｐｎａ２タンパク質に結合するアプタマー、及びそれを用いたｋｐｎａ２タンパク質の機能阻害 Download PDF

Info

Publication number
JP6619211B2
JP6619211B2 JP2015223490A JP2015223490A JP6619211B2 JP 6619211 B2 JP6619211 B2 JP 6619211B2 JP 2015223490 A JP2015223490 A JP 2015223490A JP 2015223490 A JP2015223490 A JP 2015223490A JP 6619211 B2 JP6619211 B2 JP 6619211B2
Authority
JP
Japan
Prior art keywords
protein
kpna2
rna aptamer
rna
aptamer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015223490A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017086027A (ja
JP2017086027A5 (https=
Inventor
ペンメッチャ　クマール
クマール ペンメッチャ
徳子 安原
徳子 安原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Institute of Advanced Industrial Science and Technology AIST
Original Assignee
National Institute of Advanced Industrial Science and Technology AIST
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Institute of Advanced Industrial Science and Technology AIST filed Critical National Institute of Advanced Industrial Science and Technology AIST
Priority to JP2015223490A priority Critical patent/JP6619211B2/ja
Publication of JP2017086027A publication Critical patent/JP2017086027A/ja
Publication of JP2017086027A5 publication Critical patent/JP2017086027A5/ja
Application granted granted Critical
Publication of JP6619211B2 publication Critical patent/JP6619211B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2015223490A 2015-11-13 2015-11-13 細胞核輸送受容体ｋｐｎａ２タンパク質に結合するアプタマー、及びそれを用いたｋｐｎａ２タンパク質の機能阻害 Active JP6619211B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2015223490A JP6619211B2 (ja) 2015-11-13 2015-11-13 細胞核輸送受容体ｋｐｎａ２タンパク質に結合するアプタマー、及びそれを用いたｋｐｎａ２タンパク質の機能阻害

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015223490A JP6619211B2 (ja) 2015-11-13 2015-11-13 細胞核輸送受容体ｋｐｎａ２タンパク質に結合するアプタマー、及びそれを用いたｋｐｎａ２タンパク質の機能阻害

Publications (3)

Publication Number Publication Date
JP2017086027A JP2017086027A (ja) 2017-05-25
JP2017086027A5 JP2017086027A5 (https=) 2018-11-29
JP6619211B2 true JP6619211B2 (ja) 2019-12-11

Family

ID=58769442

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015223490A Active JP6619211B2 (ja) 2015-11-13 2015-11-13 細胞核輸送受容体ｋｐｎａ２タンパク質に結合するアプタマー、及びそれを用いたｋｐｎａ２タンパク質の機能阻害

Country Status (1)

Country Link
JP (1) JP6619211B2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114317545B (zh) * 2022-01-19 2023-12-15 南京大学 一种核酸适体及其应用
EP4686758A1 (en) * 2024-07-31 2026-02-04 4basebio UK Ltd Nucleic acid for nuclear translocation
WO2026027706A1 (en) * 2024-07-31 2026-02-05 4Basebio Uk Ltd Nucleic acid for nuclear translocation

Also Published As

Publication number Publication date
JP2017086027A (ja) 2017-05-25

Similar Documents

Publication Publication Date Title
Eystathioy et al. A phosphorylated cytoplasmic autoantigen, GW182, associates with a unique population of human mRNAs within novel cytoplasmic speckles
US9062351B2 (en) Diagnostic, prognostic and therapeutic uses of long non-coding RNAs for cancer and regenerative medicine
JP2021156893A (ja) Ｒｔｋ突然変異細胞を有する患者を処置するための組成物及び方法
Viphakone et al. Luzp4 defines a new mRNA export pathway in cancer cells
EP3786177A1 (en) Modified mitochondria and use thereof
US10619161B2 (en) Aptamer capable of binding to HGF receptor
US20240150772A1 (en) Nucleolin-targeting aptamers and methods of using the same
CN101632833A (zh) 一种前列腺癌相关的基因及其用途
EP4155404A1 (en) Blood-brain barrier penetrating aptamer, and use thereof
JP6619211B2 (ja) 細胞核輸送受容体ｋｐｎａ２タンパク質に結合するアプタマー、及びそれを用いたｋｐｎａ２タンパク質の機能阻害
CN112870362B (zh) Circ-MET-1214和/或Circ-M50作为靶点在制备抗肿瘤药物中的用途
Cao et al. Immune checkpoint inhibitors mediate myocarditis by promoting macrophage polarization via cGAS/STING pathway
US20220281931A1 (en) Chemically inducible polypeptide polymerization
Høeberg et al. The invariant chain CD74 protein is a cell surface binding partner of TIMP‐1 in breast cancer cells
Han et al. Analysis of long noncoding RNAs expression profiles in the human cardiac fibroblasts with cardiac fibrosis
Alvarez et al. A two-hit mechanism for pre-mitotic arrest of cancer cell proliferation by a polyamide-alkylator conjugate
US20170088586A1 (en) Methods and compositions for controlling gene expression and treating cancer
US8058009B2 (en) Target protein and target gene in drug designing and screening method
Binet et al. DNA damage-induced interaction between a lineage addiction oncogenic transcription factor and the MRN complex shapes a tissue-specific DNA Damage Response and cancer predisposition
JP6041288B2 (ja) ホスホランバン標的修飾ｒｎａアプタマー
CN104988156B (zh) p53R175H特异性核酸适配体及其筛选方法和用途
KR102942705B1 (ko) Lag-3에 결합하는 펩타이드 및 이의 용도
WO2005049868A1 (en) Methods and agents for screening for compounds capable of modulating her2 expression
Wu et al. Dysregulation of SRSF3/circSAMD4/CIRBP Axis Promotes Iodinated Contrast-induced Acute Kidney Injury
CN114807376A (zh) 一种胶质瘤生物标志物及其应用

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20181022

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20181026

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190911

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20190911

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191030

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20191112

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20191114

R150 Certificate of patent or registration of utility model

Ref document number: 6619211

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250